CompaniesDUSA Pharmaceuticals

DUSA Pharmaceuticals

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (24)

Total Trials

24

As Lead Sponsor

11

As Collaborator

13

Total Enrollment

1,707

By Phase

PHASE1/PHASE2: 2PHASE3: 2NA: 6PHASE2: 10PHASE4: 3

By Status

COMPLETED: 20UNKNOWN: 2WITHDRAWN: 1TERMINATED: 1

Clinical Trials Pipeline24 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

Today

Hover over trial bars to see details

Recent Trials

NCT03110159Collaborator

DUSA: Cyclic PDT for the Prevention of AK & NMSC in Solid Organ Transplant Recipients

PHASE1/PHASE2Completed

Started: Aug 29, 2017 · Completed: Feb 20, 2024

NCT03024060Lead Sponsor

Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp

PHASE3Withdrawn

Started: Mar 31, 2017 · Completed: Jan 31, 2018

NCT03025724Collaborator

Photodynamic Therapy for Treatment of Cutaneous Squamous Cell Carcinoma in Situ

40 participants

Started: Jan 31, 2017 · Completed: Jan 31, 2020

NCT02632110Lead Sponsor

Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on Face

PHASE2Completed

137 participants

Started: Mar 31, 2016 · Completed: Sep 12, 2016

NCT02628236Lead Sponsor

Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)

PHASE2Completed

14 participants

Started: Feb 29, 2016 · Completed: Jul 31, 2016

View all 24 trials →

Funding History (20)

8-K

Dec 21, 2012

8-K

Dec 14, 2012

8-K

Nov 8, 2012

8-K

Sep 13, 2012

8-K

Jun 15, 2012

8-K

May 23, 2012

DEF 14A

Apr 18, 2012

8-K

Mar 8, 2012

8-K

Dec 2, 2011

8-K/A

Oct 20, 2011